Skip to content

Combined myofascial release and fascia stretching therapy for chronic heel pain

Effects of Combined Myofascial Release and Fascia Stretching Therapy Versus Myofascial Release Alone on Pain and Function in Chronic Plantar Fasciopathy: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250519065806N3
Enrollment
90
Registered
2026-05-01
Start date
2026-05-05
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Plantar Fasciopathy. Plantar fascial fibromatosis

Interventions

Intervention 1: Intervention group: After obtaining ethics approval, individuals with chronic plantar fasciopathy who met the inclusion criteria were invited to participate in the study. Participants

Sponsors

Sports Sciences Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 40 Days

Inclusion criteria

Inclusion criteria: Adults aged 25–40 years Clinical diagnosis of chronic plantar fasciopathy (symptom duration >3 months) by doctor of medicine Presence of localized tenderness at the medial calcaneal tuberosity Pain during the first steps after a period of rest Willingness to participate and provide written informed consent absence of specific spinal pathology or musculoskeletal disoredrs lower limbs No prior structured physiotherapy for the condition in the last 3 months Ability to participate in the full intervention period

Exclusion criteria

Exclusion criteria: History of corticosteroid injection in the affected foot within the previous 6 months Previous foot or ankle surgery Systemic inflammatory or rheumatologic diseases (e.g., rheumatoid arthritis, lupus) Neurological disorders affecting lower limb function (e.g., neuropathy, radiculopathy) Structural foot deformities (e.g., severe pes planus, pes cavus, or congenital deformities) Acute musculoskeletal injuries of the lower extremity during the study period Participation in other physical therapy or rehabilitation programs during the study Use of analgesic or anti-inflammatory medication that could affect pain outcomes without a stable dosage Failure to attend more than 20% of treatment sessions or poor adherence to protocol Pregnancy (for females)

Design outcomes

Primary

MeasureTime frame
Pain intensity and functional capacity. Timepoint: First week and 8 weeks. Method of measurement: Visual Analog Scale (VAS) and Foot Functional Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Seyedi

Sports Sciences Research Institute

seyedi@ssrc.ac.ir+98 21 6652 3147

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026